Connection
Rebecca Wolsky to Tumor Suppressor Protein p53
This is a "connection" page, showing publications Rebecca Wolsky has written about Tumor Suppressor Protein p53.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.361 |
|
|
|
-
Rabban JT, Wolsky RJ, Kayraklioglu N, Davies KD, Aisner DL, Devine WP. Copy Number-low/TP53-mutated Endometrial Cancer With Wild-type p53 Immunoexpression: Implications for Risk Stratification and Management When Using Next-generation Sequencing for Molecular Classification. Mod Pathol. 2026 Jun; 39(6):101005.
Score: 0.178
-
Davies KD, Smith LP, Guimaraes-Young A, Corr BR, Fisher CM, Guntupalli SR, Berning AA, Post MD, Pino D, Aisner DL, Wolsky RJ. Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care Center. Int J Gynecol Pathol. 2024 Jul 01; 43(4):335-348.
Score: 0.149
-
Haag JG, Wolsky RJ, Moroney MR, Sheren J, Sheeder J, Bitler BG, Corr BR. Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma. Int J Gynecol Pathol. 2023 Jan 01; 42(1):43-53.
Score: 0.034